Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on high-purity ...
Lyon (France), November 13, 2024, at 5:45 p.m. CET - PHAXIAM Therapeutics (Euronext: PHXM), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial infections, ...
Our recent efforts have culminated in the U.S. FDA approval of the GLORIA Phase II study protocol, the first global bacteriophage study targeting ... opportunities to further strengthen our financial ...
Later, the structure of these mysterious microbes ... Viruses can be used as tools in medicine, for example bacteriophages - viruses which infect bacteria. There should, in theory, be a ...
They were particularly drawn to features of T7 DNA polymerase—derived from the T7 bacteriophage that infects Escherichia ... polymerase’s thioredoxin binding domain (TBD), which has a structure ...
After treating samples of bacteriophages, informally known as phages ... With a little prompting, nature had produced the very type of structure that experts in the field had been attempting to ...
The viruses, however, are unlikely to affect humans. They are bacteriophages, a type of virus that preys on bacteria. The expedition into bathroom biodiversity was recently published in the journal ...
It acts as a sort of molecular fumigator to battle phages and plasmids. CRISPR-Cas9 has long been likened to a kind of genetic scissors, thanks to its ability to snip out any desired section of ...
By starting with an idea that’s already been vetted or developed as a new product or service, entrepreneurs can focus on ...